Dr. Viveca Giongo is a researcher at Center for Technological Development in Health at Oswaldo Cruz Foundation, and professor at the school of medicine, Estacio University. During her Ph.D. thesis in biochemistry at Federal University of Rio de Janeiro, she produced attenuated rotavirus and HSV particles using high hydrostatic pressure as an innovative method to obtain immunogenic viral particles. As post-doctoral at Federal Fluminense University she develops preclinical assays to identify marine terpenes and quinones derivatives as antiviral compounds against HSV and HIV. During her research fellowship in the Università Degli Studi di Napoli, she coupled terpenes and quinones in liposomes and dendrimers proving new delivery systems of marine drugs. Since 2007 she has been publishing about natural and synthetic antiviral compounds with strong inhibition upon latent diseases and now she is developing nanoparticles modified as treatment and vaccine models to zika virus.